TINA WILLIAMS: Open Payments
NPI 1871818526 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,294 in 102 payments from 16 companies in 2025. Trend: 2023 $1,888 · 2024 $2,550 · 2025 $2,294
Food & beverage: $2,228Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $425 |
| Neurocrine BioSciences, Inc. | 14 | $406 |
| Otsuka America Pharmaceutical, Inc. | 15 | $330 |
| Teva Pharmaceuticals USA, Inc. | 16 | $198 |
| Alkermes, Inc. | 9 | $198 |
| E.R. Squibb & Sons, L.L.C. | 5 | $134 |
| Supernus Pharmaceuticals, Inc. | 5 | $116 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| Collegium Pharmaceutical, Inc. | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $65 |
Products named: INGREZZA, INVEGA SUSTENNA, REXULTI, ARISTADA, COBENFY, Qelbree, AUSTEDO XR, Jornay PM.
Industry payments across GA — which companies pay providers there.
